Back to results
US 2015/0104443 A1Published application
Anti-erbb2 antibody variants
AssigneeChong Kun Dang Pharmaceutical Corp.
InventorsSeung-Kee Moon, So-Ra Park, Ki-Young An
Life of this patent
Estimating the term…
Abstract
The present invention relates to anti-ErbB2 antibody variants or antigen-binding fragments thereof, nucleic acid molecules encoding them, and their uses. The antibody variants of the present invention are capable of binding to ErbB2 with high affinity. Therefore, the antibody variants are ability to effectively prevent or treat various cancers with a low amount.
Claims12
An anti-ErbB2 antibody variant or antigen-binding fragment thereof, comprising:
- (a) a light chain variable domain;
- and
- (b) a heavy chain variable domain which amino acid sequence has at least two amino acid substitutions selected from the group consisting of:
- a substitution of Pro at position 41 with Arg, a substitution of Gly at position 96 with Asn, a substitution of Gly at position 97 with Ala, a substitution of Asp at position 98 with Trp, a substitution of Asp at position 98 with Lys, a substitution of Ala at position 100b with Ser, a substitution of Met at position 100c with Phe, a substitution of Asp at position 101 with Ala, a substitution of Asp at position 101 with Val, a substitution of Tyr at position 102 with His, and a substitution of Tyr at position 102 with Leu,
- wherein the positions are indicative of positions on the amino acid sequence of SEQ ID NO:1, and numbered according to the Kabat numbering system.
2 more elements
11-13. (canceled)
Dependencies are inferred from the claim text.